Dexcom Inc
Change company Symbol lookup
Select an option...
DXCM Dexcom Inc
GH Guardant Health Inc
NTCT Netscout Systems Inc
CIO City Office REIT Inc
HMHC Houghton Mifflin Harcourt Co
PBA Pembina Pipeline Corp
ZTS Zoetis Inc
HMPT Home Point Capital Inc
KWR Quaker Chemical Corp
TWO Two Harbors Investment Corp
Go

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.

Closing Price
$357.34
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
913,887
0

Display:

Providers:

UpdateCancel
6 providers
Yesterday's News, May 06, 2021
Comprehensive Wearable Medical Devices Help Improve Patient Care

A new trend has been evolving in the medical technology sector: wearable medical devices. In the modern technologically-driven healthcare landscape, the business model of medical device companies has evolved from device makers to problem solvers...(PR Newswire)

April 29, 2021
Dexcom Reports First Quarter 2021 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2021. First Quarter 2021 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $505.0 million U.S. revenue...(BusinessWire)

DexCom, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 29, 2021 / DexCom, Inc. (NASDAQ:DXCM) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 29, 2021 at 4:30 PM Eastern Time. (Accesswire)

April 07, 2021
Dexcom Starts Direct Distribution in the Netherlands

DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today it has ended its distribution collaboration with Zkope Healthcare and is now selling the Dexcom G6 CGM system...(BusinessWire)

April 01, 2021
Dexcom Schedules First Quarter 2021 Earnings Release and Conference Call for April 29, 2021 at 4:30 p.m. Eastern Time

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2021 financial results after market close on Thursday, April 29, 2021. Management will hold a conference call to review the company's first quarter 2021...(BusinessWire)

March 23, 2021
Dexcom Promotes Jereme Sylvain to Chief Financial Officer

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the promotion of Jereme Sylvain to the role of Executive Vice President and Chief Financial Officer. In his expanded role, Mr. Sylvain will...(BusinessWire)

February 17, 2021
Dexcom Announces Upcoming Virtual Conference Presentations

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming virtual investor conferences: Quentin Blackford, Chief Operating Officer and Chief Financial Officer, will present on behalf...(BusinessWire)

February 11, 2021
Dexcom Launches Inaugural Venture Capital Fund

DexCom, Inc. (Nasdaq: DXCM), the global leader in continuous glucose monitoring for people with diabetes, today announced the launch of Dexcom Ventures. The inaugural fund will seek to identify and invest in opportunities to supplement growth in the...(BusinessWire)

Dexcom Reports Fourth Quarter and Fiscal Year 2020 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2020. Fourth Quarter 2020 Financial Highlights: Revenue grew 23% versus the same quarter of the prior year to $568.9...(BusinessWire)

DexCom, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 11, 2021 / DexCom, Inc. (NASDAQ:DXCM) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 11, 2021 at 4:30 PM Eastern Time. (Accesswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.